Targeted & controlled bone healing
Prospectus 2018
FINANCIAL REPORTS ENGLISH GERMAN
2019
Interim results 2019  
2018
Annual Report 2018  
Interim results 2018  
2017
Kuros Annual Report 2017  
Interim results 2017

PROSPECTUS & COMPANY PRESENTATION ENGLISH GERMAN
2019
Kuros AGM Presentation May 2019    
2018
Kuros EGM Presentation Nov 2018  
Fibrin-PTH Presentation - Chicago, Oct 19  
Kuros AGM Presentation June 2018  
Company Presentation  
2017
Prospectus Supplement 29 June 2017   
Prospectus 16 June 2017   

 

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Analysts
  5. Calendar
  6. Corporate governance

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Reports & Presentations
Prospectus 2018
FINANCIAL REPORTS ENGLISH GERMAN
2019
Interim results 2019  
2018
Annual Report 2018  
Interim results 2018  
2017
Kuros Annual Report 2017  
Interim results 2017

PROSPECTUS & COMPANY PRESENTATION ENGLISH GERMAN
2019
Kuros AGM Presentation May 2019    
2018
Kuros EGM Presentation Nov 2018   
Fibrin-PTH Presentation - Chicago, Oct 19   
Kuros AGM Presentation June 2018   
Company Presentation   
2017
Prospectus Supplement 29 June 2017   
Prospectus 16 June 2017